Supplemental Information for Senate Special Committee on Aging Hearing Introduction Alzheimerās disease (AD), the most common form of dementia, was first described roughly one hundred years ago in Bavaria by Dr. Alois Alzheimer in his presentation of an early-onset (
August 20, 2009
A paper published inĀ NeuronĀ by first author Ana Griciuc and Cure Alzheimerās Fundās Research Leadership Group members Rudy Tanzi and Marco Colonna has made important headway in answering an open problem in Alzheimerās research: how do two risk genes for Alzheimerās disease, CD33 and TREM2, interact to modulate pathology and memory? ...
July 12, 2019
February 21, 2024
Washington, May 14, 2008 ā Mapping the sequence of the genes susceptible to Alzheimerās disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimerās early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimerās Fund Research Consortium, told the Senate Special ...
May 14, 2008
Cure Alzheimerās Fund will host Dr. David Holtzman for a live webinar on Thursday, May 27 at 5:30 PM.Ā Diagnosing Alzheimerās Disease: A Groundbreaking New Blood Test is free and open to the public. Registration is required. Dr. Holtzman is a co-inventor of a new blood test, PrecivityAD, designed to assist ...
May 20, 2021
January 19, 2018
By John R. Cirrito, Ph.D., and David M. Holtzman, M.D.Microdialysis Core Facility, Department of Neurology, Hope Center for Neurological Diseases, Washington University, St. Louis, MO A major contributing factor in Alzheimerās disease is the elevation of a protein called amyloid-Ī², or AĪ². Since high levels of AĪ² play a role in ...
August 20, 2009
From our 2011 Annual Report. Ā Dear Friends, On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimerās Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the ...
December 5, 2012
We will develop and implement a set of analysis approaches that will enable us to move our whole-genome sequencing analysis approaches of the family data in the Cure Alzheimerās Fund Alzheimerās Genome Projectā¢ beyond āsimple association analysis,ā fostering a deeper understanding of the underlying genetic architecture of Alzheimerās disease (AD). ...
February 1, 2024
January 30, 2024
